Items where Author is "Diermeier-Daucher, S."
 | Up a level |
Article
Machleidt, A. and Diermeier-Daucher, S. and Moegele, M. and Seitz, S. and Klinikhammer-Schalke, M. and Buchholz, S. and Ortmann, O. and Brockhoff, G. (2012) Her4-JMa-Receptor as positive prognostic Marker in triple-negative Breast Cancer. GEBURTSHILFE UND FRAUENHEILKUNDE, 72 (7). P57. ISSN 0016-5751
Brockhoff, G. and Machleidt, A. and Piendl, G. and Seegers, S. and Sassen, A. and Diermeier-Daucher, S. and Buchholz, S. and Ortmann, O. (2011) HER4 Coexpression Is Associated with Improved Recurrence EFree Survival in HER2-Positive, Herceptin Treated Patients. CANCER RESEARCH, 71 (24Supp): P1-12-23. ISSN 0008-5472, 1538-7445
Plander, M. and Seegers, S. and Ugocsai, P. and Diermeier-Daucher, S. and Ivanyi, J. and Schmitz, G. and Hofstaedter, F. and Schwarz, S. and Orso, E. and Knuechel, R. and Brockhoff, Gero (2009) Different proliferative and survival capacity of CLL-cells in a newly established in vitro model for pseudofollicles. LEUKEMIA, 23 (11). pp. 2118-2128. ISSN 0887-6924, 1476-5551
Conference or Workshop Item
Diermeier-Daucher, S. and Clarke, S. and Bradford, J. and Brockhoff, G. (2008) EFFECTS OF THYMIDINE ANALOGUES EDU AND BRDU ON CELL VIABILITY AND CELL CYCLE PROGRESSION. In: 23rd Annual Meeting of the Clinical Cytometry Society, October 12-14, 2008, Portland, Oregon.
Diermeier-Daucher, S. and Friedlaender, E. and Vereb, G. and Brockhoff, G. (2008) INITIAL MECHANISMS TRIGGERING ErbB-MEDIATED SIGNALING-IMPLICATIONS FOR EFFICIENT TARGETED THERAPY. In: 23rd Annual Meeting of the Clinical Cytometry Society, October 12-14, 2008, Portland, Oregon.
